[Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
Kitaichi
Yuji
Y
Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D000928:Antidepressive Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D003010:Clorgyline / Q000008:administration & dosage / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D008094:Lithium / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D017551:Microdialysis; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012701:Serotonin / Q000378:metabolism
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D008094:Lithium; D003010:Clorgyline; D004298:Dopamine; D009638:Norepinephrine